Clin2
NCT06967558Possibly a fitRecruiting

GLP-1 hormone role in prediabetes

PreDiabetes

Part of Hormones & metabolism clinical trials.

This study looks at how a hormone called GLP-1, made in the pancreas, affects blood sugar levels in people with borderline high blood sugar (prediabetes). It may help find new ways to prevent diabetes.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
60 people
Ages
25 years to 70 years
Study type
Interventional

Who can take part

  • You are between 25 and 70 years old.
  • Your weight has been stable, and you have never been diagnosed with diabetes.
  • Your fasting blood sugar is less than 126 mg/dL.
  • Your hemoglobin A1c (a 3-month blood sugar average) is less than 6.5%.
  • You are not taking any diabetes medications.
  • You have not had upper abdominal surgery (like gastric bypass).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06424106Recruiting
Glucagon & fasting insulin in people without type 2 diabetes

This study looks at how glucagon affects insulin release and blood sugar in people who do not have type 2 diabetes. It may help us understand normal glucose control better.

Rochester, Minnesota
NCT07089732Not yet recruiting
GLP-1 drink for blood sugar and gut health

This trial tests a special drink that may help improve blood sugar levels and gut health in people with prediabetes. It could offer a simple way to manage blood sugar and potentially prevent diabetes.

Taichung, South
NCT05119179Recruiting· Phase 4
Testing how genetics affect GLP-1 response in prediabetes

This study looks at how your genes may change how well a GLP-1–type medicine works to improve prediabetes. It focuses on adults at higher risk of developing diabetes, especially people of Mexican-American background.

Brownsville, Texas
NCT06448130Not yet recruiting· Phase 4
Can henagliflozin help reverse prediabetes?

This study tests whether a once-daily pill (henagliflozin) can help people with prediabetes return to normal blood sugar levels. If it works, it might prevent prediabetes from progressing to type 2 diabetes.

Chuzhou, Anhui
NCT07558525Not yet recruiting
Studying a new medication to reverse prediabetes

This study tests whether a new medication called chiglitazar sodium, combined with a lifestyle program, can help reverse prediabetes (when blood sugar is high but not yet diabetes). It could help you lower your blood sugar and reduce your risk of developing type 2 diabetes.

Quanzhou, Fujian
NCT07806695Recruiting· Phase 1
Understanding insulin production in gestational diabetes

This study looks at how the body makes insulin during pregnancy to understand why some women get gestational diabetes. If you join, you'll have some extra blood tests during pregnancy and after birth to help researchers learn more.

Rochester, Minnesota

Hear when a new Prediabetes trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.